|
Supports the Multidisciplinary Institute for Neuropsychiatric Diagnosis, a three-year project to create definitive medical diagnostic tests for psychiatric disorders that may underlie or result from methamphetamine abuse, including schizophrenia, depression, post-traumatic stress-disorder, attention deficit/hyperactivity disorder, or bipolar disorder (mania), and to advance treatment for the addicted and mentally ill. Funds would be used to establish this new institute, as well as to attract investigators to develop objective psychiatric diagnostic criteria. Funds would also be used to defray the cost of laboratory and clinical operations and administrative costs. The goal of this project is to gain an enhanced understanding of these disorders that can be used to design targeted treatments.
|
|
